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English Abstract
Introduction:
Cancer is one of the neoplastic diseases in which uncontrolicd proliferation of the cells
causes tumor. Cancer chemotherapy is an important treatment protocol to cure the disease
by prohibiting proliferation of the turmei"ic cells and by induction of apoptosis. 5-
Fluorouracil (5-FU) is one of the all-purpose and useful drugs utilized alone or in
combination with other remedies for the var:e{ies of cancers. This compound has limited
application due to its short half-life (10-?0 min), low lipophilic character, severe
gastrointestinal side effects, and the suppression of bone marrow. Hence, it is
recommended to use novel drug delivery systems such as liposome in order to enhance
the drug anti-cancer effect. Due to increased drug penetration, targeted drug
transportation, depot loading, increased drug stability and dissolution, improved efficacy
and decreased side effect of the drugs, liposomes are suitable choice for covering
drawbacks of chemotherapy medications which in turn makes them to be used more
broadly and effective.ly. Therefore, in this research, it was tried first to provide novel
liposomal drug delivery systems for 5-FU and then to evaluate their cytotoxic effects on
cell lines 4549 and MCF7.
Methods:
Liposomal formulations containing 5-FU were prepared using phospholipids lecithin,
HSPC, POPC, DOPC and DPPC in the presence of different amounts of cholesterol by
thin layer hydration method. lhen, Iiposomes morphologiorcharacteristics, micronized
and sub-micronized particle size distribution, particle stability andzetapotential of sub-
micron particles were assessed as time passed. Centrifugation and Frunz diffusion cell
were used to evaluate drug encapsulatioit. and its release from the manufactured
liposomes. The quantitative tests to assess, encapsulation efficiency and to find drug
release profile were carried out by an TIPLC'inethod; in which 5-FU was determined by
a reversed phase chromatography mode usihg a DAD detector (RP-HPLC-DAD) on a
C18 column with an isocratic mobile phase consisted of acidified water and methanol
(volumetric ratio of 98 to 2). Validation parameters of chromatography method were
V *Kt o-L-(ol)--r
evaluated as well. Cytotoxicity cI}'ect of the fbrmulaticns on I'dCtr7 anrl r\549 cell lines
werc also measured by MTT nrcthod.
Results:
Morphologic assessment results show that the prepared lip.osornes were mainly in the
form of multi4arnellar vesicles. The SEM images provided by electronic microscopy of
liposornes were indicating excellent formulation. Micronized particle size distribution of
majorify of liposomes was. normal up to 6 months demonstrating zuitabtre stability of
formulations as time passos. The results ot'.sub-rnicron particle size analysis and zeta
potential of most manufactured liposomes q{:owed their acceptable stability at o4e week
and 6 months. Encapsulation percentage oif-FU in liposomes at l-week and 6-month
period of times were measured in the rangl. of rc.z <EEr w""r.o/o < 37.8 and g.2S EEo
monfr,Yo < 31.9 respectively. In cytotoxic studies on two cell lines MCFT and 4549, the
amount of ICso for liposomal formulations containing 5-FU were prepared using
phospholipids lecithin, HSPC, POPC, DOPC and DPPC were in concentration range of
90.5 pg/ml S ICso < 1388.3 pelmL and 53.4 pg/ml < ICso 52725.2 pglarLrespectively.
The standard calibration curve of the analysis method showed a very good oorrelation
coefficient (0.99999).Intra-day precision ofthe rnsthod was in the range of 0.6 S RSD% S
2.3 and its inter-day precision was 0.7 S RSD% < 4.0, accuracy was between 98.8% and
IO}.|ya, and LOD and LOQ were about 40 ppb and 130 ppb respectively.,
Discussion and conclusion:
Manufacturing 5=FU with arlequate qualiff using different phospholipids by thin layer
hydration method was successful and demanstrated suitable physico chemical properties.
The profile of 5-FU release from al{ prepared liposornal formulations wbs concentration
dependent and sustained release. Regarding the hydrophilic property of the compound, it
is postulated that more drug accumulatior ca.n be occurred in the center of liposgme
vesicles and,between their hydrophilic,lllslli-layers 
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